Skip to menu Skip to content Skip to footer

2020

Journal Article

Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis

Pender, Michael P., Csurhes, Peter A., Smith, Corey, Douglas, Nanette L., Neller, Michelle A., Matthews, Katherine K., Beagley, Leone, Rehan, Sweera, Crooks, Pauline, Hopkins, Tracey J., Blum, Stefan, Green, Kerryn A., Ioannides, Zara A., Swayne, Andrew, Aftab, Blake T., Hooper, Kaye D., Burrows, Scott R., Thompson, Kate M., Coulthard, Alan and Khanna, Rajiv (2020). Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis. JCI insight, 5 (20) e144624. doi: 10.1172/jci.insight.144624

Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis

2020

Journal Article

Overview of new developments in myasthenia gravis therapy

Beer, Reuben and Blum, Stefan (2020). Overview of new developments in myasthenia gravis therapy. Advances in Clinical Neuroscience and Rehabilitation, 19 (4), 28-30. doi: 10.47795/mqnw5770

Overview of new developments in myasthenia gravis therapy

2020

Journal Article

Placebo effect in chronic inflammatory demyelinating polyneuropathy: The PATH study and a systematic review

Lewis, Richard A., Cornblath, David R., Hartung, Hans-Peter, Sobue, Gens, Lawo, John-Philip, Mielke, Orell, Durn, Billie L., Bril, Vera, Merkies, Ingemar S. J., Bassett, Paul, Cleasby, Alexa, van Schaik, Ivo N., Sabet, A., George, K., Roberts, L., Carne, R., Blum, S., Henderson, R., Van Damme, P., Demeestere, J., Larue, S., D’Amour, C., Kunc, P., Valis, M., Sussova, J., Kalous, T., Talab, R., Bednar, M., Toomsoo, T. ... PATH study group (2020). Placebo effect in chronic inflammatory demyelinating polyneuropathy: The PATH study and a systematic review. Journal of the Peripheral Nervous System, 25 (3), 230-237. doi: 10.1111/jns.12402

Placebo effect in chronic inflammatory demyelinating polyneuropathy: The PATH study and a systematic review

2020

Journal Article

Relapse patterns in NMOSD: evidence for earlier occurrence of optic neuritis and possible seasonal variation

Khalilidehkordi, Elham, Clarke, Laura, Arnett, Simon, Bukhari, Wajih, Jimenez Sanchez, Sofia, O'Gorman, Cullen, Sun, Jing, Prain, Kerri M., Woodhall, Mark, Silvestrini, Roger, Bundell, Christine S., Abernethy, David, Bhuta, Sandeep, Blum, Stefan, Boggild, Mike, Boundy, Karyn, Brew, Bruce J., Brown, Matthew, Brownlee, Wallace, Butzkueven, Helmut, Carroll, William M., Chen, Celia, Coulthard, Alan, Dale, Russell C., Das, Chandi, Fabis-Pedrini, Marzena J., Fulcher, David, Gillis, David, Hawke, Simon ... Broadley, Simon A. (2020). Relapse patterns in NMOSD: evidence for earlier occurrence of optic neuritis and possible seasonal variation. Frontiers in Neurology, 11 537, 537. doi: 10.3389/fneur.2020.00537

Relapse patterns in NMOSD: evidence for earlier occurrence of optic neuritis and possible seasonal variation

2020

Journal Article

Screening for anti-NMDAR encephalitis in psychiatry

Warren, Nicola, Flavell, Joshua, O'Gorman, Cullen, Swayne, Andrew, Blum, Stefan, Kisely, Steve and Siskind, Dan (2020). Screening for anti-NMDAR encephalitis in psychiatry. Journal of Psychiatric Research, 125, 28-32. doi: 10.1016/j.jpsychires.2020.03.007

Screening for anti-NMDAR encephalitis in psychiatry

2020

Journal Article

Evaluation of the proposed anti-N-Methyl-D-Aspartate receptor encephalitis clinical diagnostic criteria in psychiatric patients

Warren, Nicola, O’Gorman, Cullen, Blum, Stefan, Kisely, Steve, Swayne, Andrew, Flavell, Joshua and Siskind, Dan (2020). Evaluation of the proposed anti-N-Methyl-D-Aspartate receptor encephalitis clinical diagnostic criteria in psychiatric patients. Acta Psychiatrica Scandinavica, 142 (1), 52-57. doi: 10.1111/acps.13197

Evaluation of the proposed anti-N-Methyl-D-Aspartate receptor encephalitis clinical diagnostic criteria in psychiatric patients

2020

Journal Article

The clinical profile of NMOSD in Australia and New Zealand

Bukhari, Wajih, Clarke, Laura, O’Gorman, Cullen, Khalilidehkordi, Elham, Arnett, Simon, Prain, Kerri M., Woodhall, Mark, Silvestrini, Roger, Bundell, Christine S., Ramanathan, Sudarshini, Abernethy, David, Bhuta, Sandeep, Blum, Stefan, Boggild, Mike, Boundy, Karyn, Brew, Bruce J., Brownlee, Wallace, Butzkueven, Helmut, Carroll, William M., Chen, Celia, Coulthard, Alan, Dale, Russell C., Das, Chandi, Dear, Keith, Fabis-Pedrini, Marzena J., Fulcher, David, Gillis, David, Hawke, Simon, Heard, Robert ... Broadley, Simon A. (2020). The clinical profile of NMOSD in Australia and New Zealand. Journal of Neurology, 267 (5), 1431-1443. doi: 10.1007/s00415-020-09716-4

The clinical profile of NMOSD in Australia and New Zealand

2019

Journal Article

Psychiatric management of anti-NMDAR encephalitis: a cohort analysis

Warren, Nicola, O'Gorman, Cullen, McKeon, Gemma, Swayne, Andrew, Blum, Stefan and Siskind, Dan (2019). Psychiatric management of anti-NMDAR encephalitis: a cohort analysis. Psychological Medicine, 51 (3) PII S0033291719003283, 1-6. doi: 10.1017/s0033291719003283

Psychiatric management of anti-NMDAR encephalitis: a cohort analysis

2019

Journal Article

Serum and CSF anti-NMDAR antibody testing in psychiatry

Warren, Nicola, Swayne, Andrew, Siskind, Dan, O'Gorman, Cullen, Prain, Kerri, Gillis, David and Blum, Stefan (2019). Serum and CSF anti-NMDAR antibody testing in psychiatry. The Journal of neuropsychiatry and clinical neurosciences, 32 (2), appineuropsych19030079-160. doi: 10.1176/appi.neuropsych.19030079

Serum and CSF anti-NMDAR antibody testing in psychiatry

2019

Journal Article

Long-term follow-up of patients with myasthenia gravis treated with low-dose rituximab

Chan, Fiona, Swayne, Andrew, Gillis, David, Walsh, Michael, Henderson, Robert D., McCombe, Pamela A., Wong, Richard C. and Blum, Stefan (2019). Long-term follow-up of patients with myasthenia gravis treated with low-dose rituximab. Journal of Neurology, Neurosurgery and Psychiatry, 90 (8), 1-2. doi: 10.1136/jnnp-2018-319410

Long-term follow-up of patients with myasthenia gravis treated with low-dose rituximab

2019

Journal Article

Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies

Merkies, Ingemar S.J., van Schaik, Ivo N., Léger, Jean-Marc, Bril, Vera, van Geloven, Nan, Hartung, Hans-Peter, Lewis, Richard A., Sobue, Gen, Lawo, John-Philip, Durn, Billie L., Cornblath, David R., De Bleecker, Jan L., Sommer, Claudia, Robberecht, Wim, Saarela, Mika, Kamienowski, Jerzy, Stelmasiak, Zbigniew, Tackenberg, Björn, Mielke, Orell, Sabet, A., George, K., Roberts, L., Carne, R., Blum, S., Henderson, R., Van Damme, P., Demeestere, J., Larue, S., D'Amour, C. ... Zwolińska, G. (2019). Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies. Journal of the Peripheral Nervous System, 24 (1), 48-55. doi: 10.1111/jns.12302

Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies

2019

Journal Article

Restabilization treatment after intravenous immunoglobulin withdrawal in chronic inflammatory demyelinating polyneuropathy: Results from the pre-randomization phase of the Polyneuropathy And Treatment with Hizentra study

Mielke, Orell, Bril, Vera, Cornblath, David R., Lawo, John-Philip, van Geloven, Nan, Hartung, Hans-Peter, Lewis, Richard A., Merkies, Ingemar S.J., Sobue, Gen, Durn, Billie, Shebl, Amgad, van Schaik, Ivo N., Sabet, A., George, K., Roberts, L., Carne, R., Blum, S., Henderson, R., Van Damme, P., Demeestere, J., Larue, S., D'Amour, C., Kunc, P., Valis, M., Sussova, J., Kalous, T., Talab, R., Bednar, M., Toomsoo, T. ... Gable, K. (2019). Restabilization treatment after intravenous immunoglobulin withdrawal in chronic inflammatory demyelinating polyneuropathy: Results from the pre-randomization phase of the Polyneuropathy And Treatment with Hizentra study. Journal of the Peripheral Nervous System, 24 (1), 72-79. doi: 10.1111/jns.12303

Restabilization treatment after intravenous immunoglobulin withdrawal in chronic inflammatory demyelinating polyneuropathy: Results from the pre-randomization phase of the Polyneuropathy And Treatment with Hizentra study

2018

Journal Article

Epstein-Barr virus–specific T cell therapy for progressive multiple sclerosis

Pender, Michael P., Csurhes, Peter A., Smith, Corey, Douglas, Nanette L., Neller, Michelle A., Matthews, Katherine K., Beagley, Leone, Rehan, Sweera, Crooks, Pauline, Hopkins, Tracey J., Blum, Stefan, Green, Kerryn A., Ioannides, Zara A., Swayne, Andrew, Aftab, Blake T., Hooper, Kaye D., Burrows, Scott R., Thompson, Kate M., Coulthard, Alan and Khanna, Rajiv (2018). Epstein-Barr virus–specific T cell therapy for progressive multiple sclerosis. JCI Insight, 3 (22) e124714. doi: 10.1172/jci.insight.124714

Epstein-Barr virus–specific T cell therapy for progressive multiple sclerosis

2018

Journal Article

Refractory epilepsy secondary to anti-GAD encephalitis treated with DBS post SEEG evaluation: a novel case report based on stimulation findings

Gillinder, Lisa, Lehn, Alexander, Papacostas, Jason, Olson, Sarah, Blum, Stefan and Dionisio, Sasha (2018). Refractory epilepsy secondary to anti-GAD encephalitis treated with DBS post SEEG evaluation: a novel case report based on stimulation findings. Epileptic Disorders, 20 (5), 451-456. doi: 10.1684/epd.2018.0993

Refractory epilepsy secondary to anti-GAD encephalitis treated with DBS post SEEG evaluation: a novel case report based on stimulation findings

2018

Journal Article

A case of immune-mediated encephalitis related to daclizumab therapy

Devlin, Michael, Swayne, Andrew, Newman, Martin, O'Gorman, Cullen, Brown, Helen, Ong, Benjamin, Robertson, Thomas, Airey, Caroline and Blum, Stefan (2018). A case of immune-mediated encephalitis related to daclizumab therapy. Multiple Sclerosis Journal, 25 (5), 750-753. doi: 10.1177/1352458518792403

A case of immune-mediated encephalitis related to daclizumab therapy

2018

Journal Article

Genome-wide association study in Guillain-Barré syndrome

Blum, Stefan, Ji, Ying, Pennisi, David, Li, Zhixiu, Leo, Paul, McCombe, Pamela and Brown, Matthew A. (2018). Genome-wide association study in Guillain-Barré syndrome. Journal of Neuroimmunology, 323, 109-114. doi: 10.1016/j.jneuroim.2018.07.016

Genome-wide association study in Guillain-Barré syndrome

2018

Journal Article

Testing for antibodies to N-methyl-d-aspartate receptor and other neuronal cell surface antigens in patients with early psychosis

Scott, James G., Gillis, David, Swayne, Andrew and Blum, Stefan (2018). Testing for antibodies to N-methyl-d-aspartate receptor and other neuronal cell surface antigens in patients with early psychosis. The Australian and New Zealand Journal of Psychiatry, 52 (8), 727-729. doi: 10.1177/0004867418782421

Testing for antibodies to N-methyl-d-aspartate receptor and other neuronal cell surface antigens in patients with early psychosis

2018

Journal Article

Anti-glycine receptor antibody related disease: a case series and literature review

Swayne, Andrew, Tjoa, Linda, Broadley, Simon, Dionisio, Sasha, Gillis, David, Jacobson, Leslie, Woodhall, Mark R, McNabb, Andrew, Schweitzer, Daniel, Tsang, Ben, Vincent, Angela, Irani, Sarosh R, Wong, Richard, Waters, Patrick and Blum, Stefan (2018). Anti-glycine receptor antibody related disease: a case series and literature review. European Journal of Neurology, 25 (10), 1290-1298. doi: 10.1111/ene.13721

Anti-glycine receptor antibody related disease: a case series and literature review

2018

Journal Article

Intravenous versus subcutaneous immunoglobulin – Authors' reply

van Schaik, Ivo N, Mielke, Orell, Sabet, Arman, George, Koshy, Roberts, Leslie, Carne, Ross, Blum, Stefan, Henderson, Robert, Van Damme, Philip, Demeestere, Jelle, Larue, Sandrine, Pinard D'Amour, Catherine-Andree, Bril, Vera, Breiner, Ari, Kunc, Pavel, Valis, Martin, Sussova, Jana, Kalous, Tomas, Talab, Radomir, Bednar, Michal, Toomsoo, Toomas, Rubanovits, Inna, Gross-Paju, Katrin, Sorro, Ulvi, Saarela, Mika, Auranen, Mari, Pouget, Jean, Attarian, Shahram, Le Masson, Gwendal ... Mielke, Orell (2018). Intravenous versus subcutaneous immunoglobulin – Authors' reply. The Lancet Neurology, 17 (5), 393-394. doi: 10.1016/S1474-4422(18)30109-1

Intravenous versus subcutaneous immunoglobulin – Authors' reply

2018

Journal Article

The prevalence and treatment outcomes of antineuronal antibody-positive patients admitted with first episode of psychosis

Scott, James, G., Gillis, David, Ryan, Alex, E., Hargovan, Hethal, Gundarpi, Nagaraj, McKeon, Gemma, Hatherill, Sean, Newman, Martin P., Parry, Peter, Prain, Kerri, Patterson, Sue, Wong, Richard, C. W., Wilson, Robert, J. and Blum, Stefan (2018). The prevalence and treatment outcomes of antineuronal antibody-positive patients admitted with first episode of psychosis. BJ Psych Open, 4 (2), 69-74. doi: 10.1192/bjo.2018.8

The prevalence and treatment outcomes of antineuronal antibody-positive patients admitted with first episode of psychosis